Literature DB >> 21676162

High doses of topical amitriptyline in neuropathic pain: two cases and literature review.

David J Kopsky1, Jan M Keppel Hesselink.   

Abstract

Severe chronic neuropathic pain is a challenge to treat, and due to adverse effects of classical oral medication, optimal and effective dose levels are difficult to reach. Therefore, administration of topical analgesics might be an option, due to reduced adverse effects, and increased patient compliance. The aim of this article is to describe two cases treated effectively with topical amitriptyline 5% and 10%, the highest dosage described to date. The first patient was a 39-year-old man, suffering from severe intractable neuropathic pain in feet and hands, due to diabetes mellitus type II (DM-II). After application of amitriptyline 5% the patient experienced a complete relieve only in the hands, whereas after application of amitriptyline 10%, a total reduction of pain occurred within 20 minutes, lasting the whole day. The second patient was a 57-year-old man, suffering for 10 years from progressive sensory disturbances in both feet and increasing pain due to chronic idiopathic axonal polyneuropathy (CIAP). Amitriptyline 5% cream reduced pain in the toes nearly completely, but this was not the case in the heels. Amitriptyline 10% reduced pain in the feet, however, systemic adverse effects occurred, mainly drowsiness. The patient decided to stop topical treatment because of these adverse effects. These two cases suggest an analgesic dose-response effect of topical amitriptyline in painful neuropathy. Systemic adverse effects should be taken into account.
© 2011 The Authors. Pain Practice © 2011 World Institute of Pain.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21676162     DOI: 10.1111/j.1533-2500.2011.00477.x

Source DB:  PubMed          Journal:  Pain Pract        ISSN: 1530-7085            Impact factor:   3.183


  22 in total

1.  Pharmacological treatment of diabetic peripheral neuropathy.

Authors:  Kenneth Cohen; Nataliya Shinkazh; Jerry Frank; Igor Israel; Chris Fellner
Journal:  P T       Date:  2015-06

2.  Antidepressants inhibit Nav1.3, Nav1.7, and Nav1.8 neuronal voltage-gated sodium channels more potently than Nav1.2 and Nav1.6 channels expressed in Xenopus oocytes.

Authors:  Takafumi Horishita; Nobuyuki Yanagihara; Susumu Ueno; Dan Okura; Reiko Horishita; Tomoko Minami; Yuichi Ogata; Yuka Sudo; Yasuhito Uezono; Takeyoshi Sata; Takashi Kawasaki
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-09-14       Impact factor: 3.000

Review 3.  Topical Treatment of Localized Neuropathic Pain in the Elderly.

Authors:  Gisèle Pickering; Camille Lucchini
Journal:  Drugs Aging       Date:  2020-02       Impact factor: 3.923

4.  Survivorship: pain version 1.2014.

Authors:  Crystal S Denlinger; Jennifer A Ligibel; Madhuri Are; K Scott Baker; Wendy Demark-Wahnefried; Debra L Friedman; Mindy Goldman; Lee Jones; Allison King; Grace H Ku; Elizabeth Kvale; Terry S Langbaum; Kristin Leonardi-Warren; Mary S McCabe; Michelle Melisko; Jose G Montoya; Kathi Mooney; Mary Ann Morgan; Javid J Moslehi; Tracey O'Connor; Linda Overholser; Electra D Paskett; Muhammad Raza; Karen L Syrjala; Susan G Urba; Mark T Wakabayashi; Phyllis Zee; Nicole McMillian; Deborah Freedman-Cass
Journal:  J Natl Compr Canc Netw       Date:  2014-04       Impact factor: 11.908

5.  Compounded Topical Amitriptyline for Neuropathic Pain: In Vitro Release from Compounding Bases and Potential Correlation with Clinical Efficacy.

Authors:  Ayah Shakshuki; Pollen Yeung; Remigius U Agu
Journal:  Can J Hosp Pharm       Date:  2020-04-01

6.  Therapeutic utility of palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions: a case series.

Authors:  Jan M Keppel Hesselink; Thecla Am Hekker
Journal:  J Pain Res       Date:  2012-10-26       Impact factor: 3.133

7.  Treatment of chronic regional pain syndrome type 1 with palmitoylethanolamide and topical ketamine cream: modulation of nonneuronal cells.

Authors:  Jan M Keppel Hesselink; David J Kopsky
Journal:  J Pain Res       Date:  2013-03-21       Impact factor: 3.133

8.  Combination Drug Therapy for Pain following Chronic Spinal Cord Injury.

Authors:  Aldric Hama; Jacqueline Sagen
Journal:  Pain Res Treat       Date:  2012-03-18

9.  Linezolid is associated with serotonin syndrome in a patient receiving amitriptyline, and fentanyl: a case report and review of the literature.

Authors:  Lampros Samartzis; Paraskevi Savvari; Sofoklis Kontogiannis; Stavros Dimopoulos
Journal:  Case Rep Psychiatry       Date:  2013-03-04

10.  Central neuropathic pain in a patient with multiple sclerosis treated successfully with topical amitriptyline.

Authors:  David J Kopsky; Remko Liebregts; Jan M Keppel Hesselink
Journal:  Case Rep Med       Date:  2012-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.